Ifsp1

Manufactured by ChemDiv

The IFSP1 is a laboratory instrument designed for the detection and analysis of various chemical compounds. It utilizes a specialized detection method to provide precise and accurate measurements. The core function of the IFSP1 is to facilitate the identification and quantification of target analytes in a wide range of applications.

Automatically generated - may contain errors

Lab products found in correlation

Erastin, by Merck Group (2 mentions) Nigericin, by Thermo Fisher Scientific (2 mentions) Staurosporine, by Cayman Chemical (2 mentions) Mcc950, by Merck Group (2 mentions) Lipopolysaccharide lps l2880, by Merck Group (1 mentions) Nec 1, by Abcam (1 mentions) Z vad fmk, by Enzo Life Sciences (1 mentions) Fin56, by Cayman Chemical (1 mentions) Deferoxamine mesylate salt dfo, by Merck Group (1 mentions) Nec 1, by Enzo Life Sciences (1 mentions) Imp 1088, by Cayman Chemical (1 mentions) Doxycycline dox, by Merck Group (1 mentions) Fino2, by Cayman Chemical (1 mentions) Lip 1, by Selleck Chemicals (1 mentions) Ml210, by Cayman Chemical (1 mentions) Olaparib, by Selleck Chemicals (1 mentions) Lipopolysaccharides (lps), by Merck Group (1 mentions)

2 protocols using ifsp1

Ferroptosis Induction and Inhibition Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols

Menaquinone-4 (V9378), phylloquinone (V3501), menadione (M5625), MK4 epoxide (75618), vitamin K3 epoxide (51455), α-TOC (T3251), warfarin (A2250), warfarin sodium (PHR1435), dicoumarol (M1390), l-buthionine sulfoximine (BSO; B2515) N-acetyl-l-cysteine (A7250), lipopolysaccharide (LPS; L2880) and MCC950 (5381200001) were purchased from Sigma-Aldrich. Ferrostatin-1 (Fer1; 17729), RSL3 (19288), FINO₂ (25096), ML162 (20455), ML160 (23282) and staurosporine (81590) were purchased from Cayman. The following chemicals were obtained as indicated: erastin (329600, Merck Millipore), 17-AAG (A10010, Adqoo), l-glutamate (16911-22, Nacalai tesque), menadiol (M323135, TRC), iFSP1 (8009-2626, ChemDiv), liproxstatin-1 (Lip1, S7699, Selleckchem), BV-6 (S7597, Selleckchem), Trolox (56510, Fluka), recombinant mouse TNF (PMC3014, Thermo Fishier), nigericin (N1495, Thermo Fisher), zVAD-FMK (ALX-260-02, Enzo Life Sciences) and Nec 1s (2263, BioVision).

Mishima E., Ito J., Wu Z., Nakamura T., Wahida A., Doll S., Tonnus W., Nepachalovich P., Eggenhofer E., Aldrovandi M., Henkelmann B., Yamada K.I., Wanninger J., Zilka O., Sato E., Feederle R., Hass D., Maida A., Mourão A.S., Linkermann A., Geissler E.K., Nakagawa K., Abe T., Fedorova M., Proneth B., Pratt D.A, & Conrad M. (2022). A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature, 608(7924), 778-783.

+ Open protocol

+ Expand

Ferroptosis Regulators Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

Lip-1 (Selleckchem, cat. no. S7699), doxycycline (Dox; Sigma, cat. no. D9891), RSL3 (Cayman, cat. no. 19288), BSO (Sigma, cat. no. B2515), iFSP1 (ChemDiv, cat. no. 8009-2626), icFSP1 (ChemDiv, cat. no. L892-0224 or custom synthesis by Intonation Research Laboratories), erastin (Merck, cat. no. 329600), ML210 (Cayman, cat. no. Cay23282-1), FIN56 (Cayman, cat. no. Cay25180-5), FINO2 (Cayman, cat. no. Cay25096-1), deferoxamine mesylate salt (DFO; Sigma, cat. no. 138-14-7), ferrostatin-1 (Fer-1; Sigma, cat. no. SML0583), zVAD-FMK (zVAD; Enzo Life Sciences, cat. no. ALX-260-02), necrostatin-1s (Nec-1s; Enzo Life Sciences, cat. no. BV-2263-5), MCC950 (Sigma, cat. no. 5381200001), olaparib (Selleckchem, cat. no. S1060), staurosporine (STS; Cayman, cat. no. 81590), recombinant human tumour necrosis factor (TNF; R&D Systems, cat. no. NBP2-35076), Smac mimic (BV-6; Selleckchem, cat. no. S7597), nigericin (Thermo Fisher, cat. no. N1495), IMP-1088 (Cayman, cat. no. Cay25366-1) and lipopolysaccharide (LPS; Sigma, cat. no. L2880) were used in this study.

Nakamura T., Hipp C., Santos Dias Mourão A., Borggräfe J., Aldrovandi M., Henkelmann B., Wanninger J., Mishima E., Lytton E., Emler D., Proneth B., Sattler M, & Conrad M. (2023). Phase separation of FSP1 promotes ferroptosis. Nature, 619(7969), 371-377.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!